Introduction: Common variable immunodeficiency (CVID) is a primary immune disorder characterized by impaired antibody production, which is in many instances secondary to defective T cell function (TCVID). Objectives: We have previously identified a subset of T-CVID patients characterized by defective expression of Vav1, a guanine nucleotide exchanger which couples the T-cell antigen receptor to reorganization of the actin cytoskeleton. Aims: Here we have addressed the possibility that an intrinsic defect in the Vav1 gene might underlie the reduction in Vav protein observed in T cells from these patients. Methods: We report the identification in one T-CVID patient of a heterozygous deletion in Vav1. Results: The gene deletion, spanning exons 2-27, accounts for the reduction in Vav1 mRNA and protein in T cells from this patient. The disease related pedigree of this patient suggests a de novo origin of the Vav1 deletion. Conclusions: The findings highlights Vav1 as an autosomal dominant disease gene associated with CVID with defective T-cell function.
Troilo, A., Capitani, N., Ariani, F., Amedei, A., Pezzicoli, A., Matucci, A., et al. (2012). VAV1 HAPLOINSUFFICIENCY IN COMMON VARIABLE IMMUNODEFICIENCY WITH DEFECTIVE T CELL FUNCTION. In 15th Biennial Meeting of the European Society for Immunodeficiency (pp.401-401). Cham : Springer.
VAV1 HAPLOINSUFFICIENCY IN COMMON VARIABLE IMMUNODEFICIENCY WITH DEFECTIVE T CELL FUNCTION
Capitani, N.;Ariani, F.;Pezzicoli, A.;Renieri, A.;Baldari, C. T.;D'Elios, M. M.
2012-01-01
Abstract
Introduction: Common variable immunodeficiency (CVID) is a primary immune disorder characterized by impaired antibody production, which is in many instances secondary to defective T cell function (TCVID). Objectives: We have previously identified a subset of T-CVID patients characterized by defective expression of Vav1, a guanine nucleotide exchanger which couples the T-cell antigen receptor to reorganization of the actin cytoskeleton. Aims: Here we have addressed the possibility that an intrinsic defect in the Vav1 gene might underlie the reduction in Vav protein observed in T cells from these patients. Methods: We report the identification in one T-CVID patient of a heterozygous deletion in Vav1. Results: The gene deletion, spanning exons 2-27, accounts for the reduction in Vav1 mRNA and protein in T cells from this patient. The disease related pedigree of this patient suggests a de novo origin of the Vav1 deletion. Conclusions: The findings highlights Vav1 as an autosomal dominant disease gene associated with CVID with defective T-cell function.File | Dimensione | Formato | |
---|---|---|---|
2012_Article_ESID2012LATEBREAKERSORALPRESEN.pdf
non disponibili
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
503.25 kB
Formato
Adobe PDF
|
503.25 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1163400